BIOTIME INC Business Finance Contracts & Agreements
94 Contracts & Agreements
- Credit Agreements (10 contracts)
- Escrow Agreements (1)
- Exchange Agreements (2)
- Note Agreements (4)
- Purchase Agreements (7)
- Registration Rights Agreements (3)
- Security Agreements (4)
- Share Agreements (6)
- Shareholders Agreements (2)
- Stock Agreements (30)
- Subscription Agreements (2)
- Underwriting Agreements (5)
- Warrant Agreements (18)
- Form of Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and Broadwood Partners, L.P (Filed With SEC on November 20, 2024)
- Form of Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and the purchaser parties thereto (Filed With SEC on November 20, 2024)
- Form of Placement Agent Warrant (Filed With SEC on November 20, 2024)
- Form of Common Stock Purchase Warrant issued pursuant to the Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and Broadwood Partners,... (Filed With SEC on November 20, 2024)
- Form of Common Stock Purchase Warrant issued pursuant to the Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and the purchaser... (Filed With SEC on November 20, 2024)
- Amendment to Stock Option Agreements dated December 4, 2023 between Registrant and Gary S. Hogge (Filed With SEC on March 7, 2024)
- Form of Stock Purchase Agreement (Filed With SEC on February 6, 2024)
- Share Purchase and Transfer Agreement, dated June 16, 2017, by and among registrant, HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on June 17, 2022)
- Debt and Note Purchase Agreement, dated June 16, 2017, and Amendment to Debt and Note Purchase Agreement, dated as of June 29, 2017, between registrant and HBL-Hadasit... (Filed With SEC on June 17, 2022)
- Description of Capital Stock of the Registrant (Filed With SEC on March 11, 2021)
- 2012 Plan Form of Restricted Stock Unit (Filed With SEC on March 12, 2020)
- Description of Capital Stock of the Registrant (Filed With SEC on March 12, 2020)
- Shareholder Agreement, dated August 30, 2018 between BioTime, Inc. and Juvenescence Limited (Filed With SEC on August 31, 2018)
- Convertible Promissory Note, dated August 30, 2018 (Filed With SEC on August 31, 2018)
- Stock Purchase Agreement, dated August 30, 2018, between BioTime, Inc., AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on August 31, 2018)
- Option to Purchase Shares of AgeX Therapeutics, Inc., dated August 4, 2017, granted by BioTime, Inc. to Alfred D. Kingsley (Filed With SEC on November 9, 2017)
- Form of AgeX Therapeutics, Inc. Stock Option Agreement (Filed With SEC on October 16, 2017)
- Underwriting Agreement, dated October 13, 2017, by and between BioTime, Inc. and Raymond James & Associates, Inc., as representative of the underwriters named therein (Filed With SEC on October 13, 2017)
- Share Purchase and Transfer Agreement, dated June 16, 2017, by and among BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd. (Portions of this exhibit... (Filed With SEC on August 9, 2017)
- Debt and Note Purchase Agreement, dated June 16, 2017, as amended June 29, 2017, between BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. (Portions of this exhibit have been... (Filed With SEC on August 9, 2017)
- Form of Cell Cure Neurosciences Ltd. Share Option Plan Option Agreement (Filed With SEC on March 16, 2017)
- Cell Cure Neurosciences Ltd. Share Option Plan (Filed With SEC on March 16, 2017)
- Underwriting Agreement, dated February 10, 2017, between BioTime, Inc. and Raymond James & Associates, Inc., as representative of the underwriters named therein (Filed With SEC on February 13, 2017)
- Form of Warrant (Filed With SEC on August 29, 2016)
- Alternate Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Underwriting Agreement, dated June 16, 2016, between BioTime, Inc. and Oppenheimer & Co. Inc (Filed With SEC on June 17, 2016)
- Warrant Agreement between Asterias Biotherapeutics, Inc. and American Stock Transfer & Trust Company (Filed With SEC on May 10, 2016)
- Share Transfer Agreement by and among Asterias Biotherapeutics, Inc., BioTime, Inc., and ES Cell International Pte Ltd (Filed With SEC on February 18, 2016)
- Subscription Agreement, dated September 29, 2015, between OncoCyte Corporation and BioTime, Inc (Filed With SEC on November 9, 2015)
- Stock Purchase Agreements between BioTime, Inc. and certain investors (Filed With SEC on November 9, 2015)
- Stock Purchase Agreements, dated September 14, 2015, between BioTime, Inc. and certain investors (Filed With SEC on November 9, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on October 2, 2015)
- Letter Agreement with Union Underwriting & Finances Ltd (Filed With SEC on September 25, 2015)
- Form of Escrow Agreement (Filed With SEC on September 25, 2015)
- Form of Stock Purchase Agreements (Filed With SEC on September 25, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on September 14, 2015)
- Subscription Agreements between Asterias Biotherapeutics, Inc. and the investors named therein (Filed With SEC on March 11, 2015)
- Underwriting Agreement, dated February 5, 2015, by and between Asterias Biotherapeutics, Inc. and MLV & Co. LLC (Filed With SEC on February 6, 2015)
- Form of Stock Purchase Agreement (Filed With SEC on October 3, 2014)
